186 related articles for article (PubMed ID: 15611079)
1. Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity.
Kochupurakkal BS; Harari D; Di-Segni A; Maik-Rachline G; Lyass L; Gur G; Kerber G; Citri A; Lavi S; Eilam R; Chalifa-Caspi V; Eshhar Z; Pikarsky E; Pinkas-Kramarski R; Bacus SS; Yarden Y
J Biol Chem; 2005 Mar; 280(9):8503-12. PubMed ID: 15611079
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
[TBL] [Abstract][Full Text] [Related]
3. Bivalence of EGF-like ligands drives the ErbB signaling network.
Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
[TBL] [Abstract][Full Text] [Related]
4. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes.
Shelly M; Pinkas-Kramarski R; Guarino BC; Waterman H; Wang LM; Lyass L; Alimandi M; Kuo A; Bacus SS; Pierce JH; Andrews GC; Yarden Y
J Biol Chem; 1998 Apr; 273(17):10496-505. PubMed ID: 9553109
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGF-like Growth Factor.
Takazaki R; Shishido Y; Iwamoto R; Mekada E
J Biol Chem; 2004 Nov; 279(45):47335-43. PubMed ID: 15331606
[TBL] [Abstract][Full Text] [Related]
6. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP; Dempsey PJ; Dunbar AJ
Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
[TBL] [Abstract][Full Text] [Related]
7. Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis.
Stein RA; Staros JV
BMC Evol Biol; 2006 Oct; 6():79. PubMed ID: 17026767
[TBL] [Abstract][Full Text] [Related]
8. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.
Uchida T; Wada K; Akamatsu T; Yonezawa M; Noguchi H; Mizoguchi A; Kasuga M; Sakamoto C
Biochem Biophys Res Commun; 1999 Dec; 266(2):593-602. PubMed ID: 10600548
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
10. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ
Nature; 1997 May; 387(6632):509-12. PubMed ID: 9168114
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
[TBL] [Abstract][Full Text] [Related]
12. EMR4, a novel epidermal growth factor (EGF)-TM7 molecule up-regulated in activated mouse macrophages, binds to a putative cellular ligand on B lymphoma cell line A20.
Stacey M; Chang GW; Sanos SL; Chittenden LR; Stubbs L; Gordon S; Lin HH
J Biol Chem; 2002 Aug; 277(32):29283-93. PubMed ID: 12023293
[TBL] [Abstract][Full Text] [Related]
13. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display.
Stortelers C; Souriau C; van Liempt E; van de Poll ML; van Zoelen EJ
Biochemistry; 2002 Jul; 41(27):8732-41. PubMed ID: 12093292
[TBL] [Abstract][Full Text] [Related]
14. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.
Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C
J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710
[TBL] [Abstract][Full Text] [Related]
15. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily.
Strachan L; Murison JG; Prestidge RL; Sleeman MA; Watson JD; Kumble KD
J Biol Chem; 2001 May; 276(21):18265-71. PubMed ID: 11278323
[TBL] [Abstract][Full Text] [Related]
16. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
Graus-Porta D; Beerli RR; Daly JM; Hynes NE
EMBO J; 1997 Apr; 16(7):1647-55. PubMed ID: 9130710
[TBL] [Abstract][Full Text] [Related]
17. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
[TBL] [Abstract][Full Text] [Related]
18. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
Komurasaki T; Toyoda H; Uchida D; Morimoto S
Oncogene; 1997 Dec; 15(23):2841-8. PubMed ID: 9419975
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of epigen, the last EGFR ligand.
Schneider MR; Yarden Y
Semin Cell Dev Biol; 2014 Apr; 28():57-61. PubMed ID: 24374012
[TBL] [Abstract][Full Text] [Related]
20. Alternative intracellular routing of ErbB receptors may determine signaling potency.
Waterman H; Sabanai I; Geiger B; Yarden Y
J Biol Chem; 1998 May; 273(22):13819-27. PubMed ID: 9593726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
